Exclusive: CVS and its PBM agree to pay $45 million to Illinois for failing to pass drug rebates

Also: Jiankui He, creator of CRISPR-edited children, relocates to a Chinese medical tourism hub

July 24, 2024 Check out STAT+

Sponsored By

Matt Rourke/AP STAT+ | CVS and its PBM agree to pay $45 million to Illinois for failing to pass drug rebates "This will keep CVS from holding on to any manufacturer dollars," said Chris Brown of McAteer, a consulting firm. "This rips down a wall." By Ed Silverman STAT+ | Sage suffers pipeline setback with failure of drug to treat essential tremor New results are a significant setback for Sage's neurology pipeline, and its effort to develop a successful medicine beyond Zurzuvae. By Adam Feuerstein Robotic aid helped improve balance, gait in children with cerebral palsy One of largest studies using exoskeletons for rehab in children with cerebral palsy demonstrated a limited gain in gross motor function. By Timmy Broderick Ajay Kumar Chaurasiya/ Wikimedia Commons Hospitals, labs, and health departments try to cope with blood culture bottle shortage The CDC sent an alert Tuesday about a shortage of blood culture medium bottles that could stretch into September. By Helen Branswell Merck lays off workers amid rough pharma job market Today's biotech news includes the latest on Pfizer's hemophilia A therapy, Jeff Shuren's exit from the FDA, and more. By Elaine Chen Key disability civil rights law will get a big refresh under Sen. Bob Casey's new bill Sen. Bob Casey Jr. (D-Pa.) will introduce legislation Wednesday to strengthen and expand a critical part of the Rehabilitation Act of 1973. By Timmy Broderick Mark Schiefelbein/AP STAT+ | Jiankui He, creator of CRISPR-edited children, relocates to a Chinese medical tourism hub The "CRISPR babies" scientist has moved to the island of Hainan, a beach resort and home to an experiment in medical tourism. By Megan Molteni

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser